Table 1.
Epidemiological data, comorbidities, and hospitalization data of HBoV-infected children and comparison between Group A and Group B.
| Epidemiological Data | Total (n = 165) |
Group A (n = 69) | Group B (n = 96) | p-Value |
|---|---|---|---|---|
| Age (years) < 2, n (%) | 107 (64.8) | 43 (62.3) | 64 (66.7) | 0.229 |
| 2–6, n (%) | 55 (33.4) | 26 (37.7) | 29 (30.2) | |
| >6, n (%) | 3 (1.8) | 0 (0) | 3 (3.1) | |
| Median (IQR), years | 1.5 (1.1–2.7) | 1.6 (1.1–2.8) | 1.5 (1.1–2.7) | 0.802 |
| Gender, male, n (%) | 95 (57.6) | 45 (65.2) | 50(52.1) | 0.09 |
| Comorbidities | ||||
|
5 (3) | 2 (2.9) | 3 (3.1) | 0.933 |
|
29 (17.5) | 13 (18.8) | 16 (16.7) | 0.717 |
| Pediatric Ward admission, n (%) | 95 (57.6) | 40 (57.9) | 55 (57.3) | 0.931 |
| PICU admission, n (%) | 12 (7.3) | 0 (0) | 12 (12.5) | <0.001 |
| LOS, days, n (IQR) | 5 (2–7) | 3 (2–6) | 5 (2–9) | 0.041 |
RDH: respiratory disease history; PICU: pediatric intensive care unit; LOS: length of stay.